The Director-General of the Organization of Eastern Caribbean States (OECS), Dr. Didacus Jules, informed the media that a shipment of 9000 units of Interferon arrived in Saint Lucia which was signed on by the Organization. This medicine will be distributed for use in the fight against Covid-19 in Saint Lucia and other OECS member states. Interferon was developed in 1986 by the Center for Genetic Engineering and Biotechnology (CIGB). The Interferon alfa 2B human recombinant has benefited thousands of Cuban patients since its introduction more than three decades ago into the national health system. The product has shown its effectiveness and safety in the therapy of viral diseases, such as Hepatitis B and C, the Herpes Zoster Virus, HIV-AIDS and Dengue Fever. It has the property of interfering with viral multiplication within cells and has also been used in the treatment of different types of carcinomas.